Skip to Main Content

Paper Details

Phase 4 Multinational Multicenter Retrospective and Prospective Real-World Study of Nivolumab in Recurrent and Metastatic Squamous Cell Carcinoma of the Head and Neck.
Cancers (Basel)
2
2023
  • 1 - 1

Datasets